Tag Archives: Skyline Ventures

More Good News for DisRNA Research

July 15, 2008 – 12:33 pm

As a follow on to the potential of 27mer DsiRNAs as a key platform for drug discovery and development, we are happy to report:
15.07.2008 13:34
Dicerna Pharmaceuticals, a Second Generation RNA Interference Company, Completes Second Closing of Series A Financing; Unveils Strategic Focus
Dicerna Pharmaceuticals, Inc. (www.dicerna.com), an RNA interference company developing novel therapeutics utilizing proprietary [...]

By Pete Shuster | Posted in Companies | Also tagged , , , , , , | Comments (0)